SCHEMBL6630405

SCHEMBL6630405

CCOC(=O)C(Cc1ccc(CCCc2nc(-c3ccccc3)oc2C)cc1)n1ccnn1

nearest known ligand 0.84

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.84
PPARA Q07869 15/20 0.66
PPARD Q03181 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5727010 0.94 PPARG (0.85) PPARGPPARAPPARD
SCHEMBL5726106 0.91 PPARG (1.00) PPARGPPARAPPARD
SCHEMBL5727420 0.89 PPARG (0.83) PPARGPPARAPPARD
SCHEMBL5726477 0.87 PPARG (0.83) PPARGPPARAPPARD
SCHEMBL5726600 0.86 PPARG (0.82) PPARGPPARAPPARD
SCHEMBL6387621 0.83 PPARG (0.83) PPARGPPARAPPARD
SCHEMBL6385358 0.82 PPARG (0.83) PPARGPPARAPPARD
SCHEMBL5727595 0.81 PPARG (0.82) PPARGPPARAPPARD
SCHEMBL5727602 0.81 PPARG (0.82) PPARGPPARAPPARD
SCHEMBL5727422 0.79 PPARG (1.00) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1423363-A1 ORAL ANTIDIABETIC AGENTS Warner-Lambert Company LLC (US) 2004-06-02 EP claimed
WO-2003018553-A1 ORAL ANTIDIABETIC AGENTS WARNER-LAMBERT COMPANY LLC (US) 2003-03-06 WO claimed